Skip to main content
. 2024 May 20;9:132. doi: 10.1038/s41392-024-01823-2

Table 13.

The typical and clinically developed microbiota inhibitor

Drug Highest Phase Indications Identifier Status
Bismuth colloidal pectin granules quadruple therapy IV Gastric cancer, helicobacter pylori infection NCT04660123 Completed
IV Gastric cancer, helicobacter Pylori infection NCT04209933 Completed
Itraconazole IV Hematologic neoplasms NCT02895529 Terminated

Source: All the information is derived from ClinicalTrials.gov (https://www.clinicaltrials.gov)